Haemonetics Earnings
NYSE: HAEHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$1.30
Haemonetics earnings summary
Haemonetics is scheduled to report Sep/2026 earnings on Nov 5, 2026 before the market opens, with analysts expecting EPS of $1.30. In its most recent report on Aug 6, 2026 (Q1 2027), HAE posted EPS of $0.72. Revenue for the quarter was $339.4 million.
Quarterly EPS is up 2.9% from the same quarter a year earlier. Across the last 16 reports, HAE shares moved an average of 3.4% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
HAE earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $0.72 | — | +3.4% |
| May 20, 2026 | — | $-0.41 | — | +3.5% |
| Feb 5, 2026 | — | $0.95 | — | -2.7% |
| Nov 6, 2025 | — | $0.81 | — | +7.5% |
| Aug 7, 2025 | — | $0.70 | — | -0.5% |
| May 21, 2025 | — | $1.17 | — | +2.5% |
| Feb 6, 2025 | — | $0.74 | — | +5.1% |
| Nov 7, 2024 | — | $0.66 | — | +2.1% |
| Aug 8, 2024 | — | $0.74 | — | -2.2% |
| May 20, 2024 | — | $0.40 | — | -4.8% |
| Feb 8, 2024 | — | $0.61 | — | -2.5% |
| Nov 2, 2023 | — | $0.48 | — | -2.6% |
| Aug 8, 2023 | — | $0.80 | — | -7.0% |
| May 22, 2023 | — | $0.58 | — | +5.9% |
| Feb 7, 2023 | — | $0.64 | — | +0.9% |
| Nov 8, 2022 | — | $0.64 | — | +0.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.